2010Chronic Pathematology JournalRequires access

A Clinical Study of the Efficacy of Quetiapine Combined with Paroxetine in the Treatment of Obsession

Guo Pin

Open publisher page 0 citations

Abstract

Objective:To evaluate the clinical efficiency and safety of quetiapine combined with paroxetine in treating obsession.Methods:47 patients with obsession were randomly divided into paroxetine group and quetiapine with paroxetine group,and then follow up for 8 weeks.Yale-Brown Obsessive-compulsive disorder scale(Y-BOCS),Hamilton anxiety scale(HAMA)and treatment emergent symptom scale(TESS)were used to evaluate the efficiency and adverse effects.Results:The scores of Y-BOCS and HAMA at the base time were Similarly.Yet the Y-BOCS score of the quetiapine with paroxetine group(12.4±4.7)was lower than it of the paroxetine group(16.1 ±3.9,t=2.576,P=0.03).The HAMA score of the quetiapine with paroxetine group(6.9±3.8)was lower than the it of the paroxetine group(10.1±3.6,t=2.236,P=0.017).Conclusion:Quetiapine combined with paroxetine have exacta efficiency and safety in treating Obsession.

About this research paper

What this paper is about

Objective:To evaluate the clinical efficiency and safety of quetiapine combined with paroxetine in treating obsession.Methods:47 patients with obsession were randomly divided into paroxetine group and quetiapine with paroxetine group,and then follow up for 8 weeks.Yale-Brown Obsessive-compulsive disorder scale(Y-BOCS),Hamilton anxiety scale(HAMA)and treatment emergent symptom scale(TESS)were used to evaluate the efficiency and adverse effects.Results:The scores of Y-BOCS and HAMA at the base time were Similarly.Yet the Y-BOCS score of the quetiapine with paroxetine group(12.4±4.7)was lower than it of the paroxetine group(16.1 ±3.9,t=2.576,P=0.03).The HAMA score of the quetiapine with paroxetine group(6.9±3.8)was lower than the it of the paroxetine group(10.1±3.6,t=2.236,P=0.017).Conclusion:Quetiapine combined with paroxetine have exacta efficiency and safety in treating Obsession.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the clinical efficiency and safety of quetiapine combined with paroxetine in treating obsession.Methods:47 patients with obsession were randomly divided into paroxetine group and quetiapine with paroxetine group,and then follow up for 8 weeks.Yale-Brown Obsessive-compulsive disorder scale(Y-BOCS),Hamilton anxiety scale(HAMA)and treatment emergent symptom scale(TESS)were used to evaluate the efficiency and adverse effects.Results:The scores of Y-BOCS and HAMA at the base time were Similarly.Yet the Y-BOCS score of the quetiapine with paroxetine group(12.4±4.7)was lower than it of the paroxetine group(16.1 ±3.9,t=2.576,P=0.03).The HAMA score of the quetiapine with paroxetine group(6.9±3.8)was lower than the it of the paroxetine group(10.1±3.6,t=2.236,P=0.017).Conclusion:Quetiapine combined with paroxetine have exacta efficiency and safety in treating Obsession.

Key concepts: Paroxetine, Quetiapine, Medicine, Quetiapine Fumarate, Psychiatry, Clinical efficacy, Internal medicine, Rating scale

Related papers

Back to paper searchBrowse research topicsOriginal source
A Clinical Study of the Efficacy of Quetiapine Combined with Paroxetine in the Treatment of Obsession — Research Paper | ScholarLens